Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 29, 2017

DrugPatentWatch Database Preview

Loratadine - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for loratadine and what is the scope of patent protection?

is the generic ingredient in eleven branded drugs marketed by Perrigo, Bayer Healthcare Llc, Taro, Teva, Sandoz, Perrigo Pharma Intl, Marksans Pharma, Wockhardt, Silarx, Pfizer, Ranbaxy Labs Ltd, Sun Pharm Inds Ltd, Mylan, Apotex Inc, Taro Pharm, and Actavis Labs Fl Inc, and is included in thirty-six NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Loratadine has thirty-one patent family members in twenty-eight countries.

There are thirty-nine drug master file entries for loratadine. One hundred and thirty suppliers are listed for this compound.

Summary for Generic Name: loratadine

Drug Master File Entries: see list39
Suppliers / Packagers: see list130
Bulk Api Vendors: see list83
Clinical Trials: see list9
Patent Applications: see list6,151
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:loratadine at DailyMed

Pharmacology for Ingredient: loratadine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bayer Healthcare Llc
TABLET, ORALLY DISINTEGRATING;ORAL020704-002Nov 27, 2002OTCYesYes► Subscribe► Subscribe
SYRUP;ORAL075505-001Nov 7, 2003OTCNoNo► Subscribe► Subscribe
SUSPENSION;ORAL021734-001Oct 4, 2005OTCYesYes► Subscribe► Subscribe
Actavis Labs Fl Inc
TABLET, ORALLY DISINTEGRATING;ORAL075990-001Nov 3, 2003OTCNoNo► Subscribe► Subscribe
Sun Pharm Inds Ltd
loratadine; pseudoephedrine sulfate
TABLET, EXTENDED RELEASE;ORAL076557-001Sep 22, 2004OTCNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Find generic sources and suppliers
  • Formulary management

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus